Cathepsin S required for normal MHC class II peptide loading and germinal center development.

[1]  I. Mellman,et al.  Developmental Regulation of Invariant Chain Proteolysis Controls MHC Class II Trafficking in Mouse Dendritic Cells , 1998, Cell.

[2]  R. Mitchell,et al.  Cathepsin S activity regulates antigen presentation and immunity. , 1998, The Journal of clinical investigation.

[3]  A. Rudensky,et al.  Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. , 1998, Science.

[4]  S. Sudowe,et al.  Antigen dose‐dependent differences in IgE antibody production are not due to polarization towards Th1 and Th2 cell subsets , 1998, European journal of immunology.

[5]  M. Juliano,et al.  Mapping of the T-Cell Epitope in the Major 43-Kilodalton Glycoprotein of Paracoccidioides brasiliensisWhich Induces a Th-1 Response Protective against Fungal Infection in BALB/c Mice , 1998, Infection and Immunity.

[6]  D. Lo,et al.  The Density of the Class II MHC T Cell Receptor Ligand Influences IFN-γ/IL-4 Ratios in Immune Responsesin Vivo , 1998 .

[7]  Douglas,et al.  Neither interleukin‐6 nor signalling via tumour necrosis factor receptor‐1 contribute to the adjuvant activity of Alum and Freund’s adjuvant , 1998, Immunology.

[8]  C. Peters,et al.  Degradation of Mouse Invariant Chain: Roles of Cathepsins S and D and the Influence of Major Histocompatibility Complex Polymorphism , 1997, The Journal of experimental medicine.

[9]  J. Sprent,et al.  Thymic selection by a single MHC/peptide ligand produces a semidiverse repertoire of CD4+ T cells. , 1997, Immunity.

[10]  M. Lotze,et al.  FLT3 ligand induces the generation of functionally active dendritic cells in mice. , 1997, Cellular immunology.

[11]  M. Bevan,et al.  In thymic selection, peptide diversity gives and takes away. , 1997, Immunity.

[12]  I. Mellman,et al.  Ii Chain Controls the Transport of Major Histocompatibility Complex Class II Molecules to and from Lysosomes , 1997, The Journal of cell biology.

[13]  M. Utsuyama,et al.  Positive and negative CD4+ thymocyte selection by a single MHC class II/peptide ligand affected by its expression level in the thymus. , 1997, Immunity.

[14]  C. Arpin,et al.  Germinal center development , 1997, Immunological reviews.

[15]  C. Watts,et al.  Capture and processing of exogenous antigens for presentation on MHC molecules. , 1997, Annual review of immunology.

[16]  T. Schountz,et al.  MHC genotype controls the capacity of ligand density to switch T helper (Th)-1/Th-2 priming in vivo. , 1996, Journal of immunology.

[17]  E. Maraskovsky,et al.  Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified , 1996, The Journal of experimental medicine.

[18]  G. Kelsoe,et al.  The germinal center: a crucible for lymphocyte selection. , 1996, Seminars in immunology.

[19]  H. Ploegh,et al.  Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. , 1996, Immunity.

[20]  P. A. Peterson,et al.  Antigen Presentation and T Cell Development in H2-M-Deficient Mice , 1996, Science.

[21]  C. Benoist,et al.  Mice Lacking H2-M Complexes, Enigmatic Elements of the MHC Class II Peptide-Loading Pathway , 1996, Cell.

[22]  Partho Ghosh,et al.  The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3 , 1995, Nature.

[23]  K. Murphy,et al.  The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model , 1995, The Journal of experimental medicine.

[24]  D. Weber,et al.  DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide. , 1995, Immunity.

[25]  D. Zaller,et al.  Mediation by HLA-DM of dissociation of peptides from HLA-DR , 1995, Nature.

[26]  K. Shokat,et al.  Antigen-induced B-cell death and elimination during germinal-centre immune responses , 1995, Nature.

[27]  Kenneth G. C. Smith,et al.  Soluble antigen can cause enhanced apoptosis of germinal-centre B cells , 1995, Nature.

[28]  A. Sette,et al.  Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo , 1995, The Journal of experimental medicine.

[29]  H. Ploegh,et al.  How MHC class II molecules acquire peptide cargo: biosynthesis and trafficking through the endocytic pathway. , 1995, Annual review of cell and developmental biology.

[30]  G. Dranoff,et al.  Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis. , 1994, Science.

[31]  A. C. Webb,et al.  Human cathepsin S: chromosomal localization, gene structure, and tissue distribution. , 1994, The Journal of biological chemistry.

[32]  C. Benoist,et al.  Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain. , 1994, Science.

[33]  Ronald N. Germain,et al.  MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation , 1994, Cell.

[34]  P. Cresswell,et al.  Assembly, transport, and function of MHC class II molecules. , 1994, Annual review of immunology.

[35]  L. Adorini,et al.  Epitope-specific enhancement of antigen presentation by invariant chain , 1993, The Journal of experimental medicine.

[36]  Jim Miller,et al.  Antigen presentation enhanced by the alternatively spliced invariant chain gene product p41 , 1992, Nature.

[37]  D. Rich,et al.  Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease. , 1992, The Journal of biological chemistry.

[38]  H. Grey,et al.  Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing , 1983, The Journal of experimental medicine.